Table 2.
Covariate | Coefficient | SE | p |
---|---|---|---|
Baseline IGF-1 level associations with baseline covariatesa | |||
Age, years | −1.61 | 0.30 | <.0001 |
Race (white, reference) | 0.00 | ||
Black | −16.77 | 7.42 | .02 |
Other race | −28.14 | 9.03 | .002 |
Baseline WHR (per 0.1 change) | −11.68 | 4.17 | .005 |
CD4 count (>200 cells/μl) | 13.47 | 5.88 | .02 |
Albumin (g/dl) | 24.60 | 5.51 | <.0001 |
Baseline to week 96 change IGF-1 level associations with baseline and change covariatesb | |||
Female sex | 13.33 | 5.16 | .01 |
Change in WHR (per 0.1 change) | −10.56 | 3.66 | .004 |
HIV-1 RNA level (>log5) | −11.39 | 4.86 | .02 |
Albumin (g/dl) | −10.80 | 4.50 | .02 |
Also included sex, HIV-1 RNA, BMI, treatment group.
Also included age, race, BMI week 96, CD4+ count week 96, baseline to week 96 change in CD4+ count, baseline to week 96 change in BMI, WHR week 96, and treatment group.
IGF-1, insulin-like growth factor-1.